Microstructure predicts non-motor outcomes following deep brain stimulation in Parkinson's disease
- PMID: 38762510
- PMCID: PMC11102428
- DOI: 10.1038/s41531-024-00717-y
Microstructure predicts non-motor outcomes following deep brain stimulation in Parkinson's disease
Abstract
Deep brain stimulation of the subthalamic nucleus (STN-DBS) effectively treats motor and non-motor symptoms in advanced Parkinson's disease (PD). As considerable interindividual variability of outcomes exists, neuroimaging-based biomarkers, including microstructural metrics, have been proposed to anticipate treatment response. In this prospective open-label study, we sought to detect microstructural properties of brain areas associated with short-term non-motor outcomes following STN-DBS. Thirty-seven PD patients underwent diffusion MRI and clinical assessments at preoperative baseline and 6-month follow-up. Whole brain voxel-wise analysis assessed associations between microstructural metrics and non-motor outcomes. Intact microstructure within specific areas, including the right insular cortex, right putamen, right cingulum, and bilateral corticospinal tract were associated with greater postoperative improvement of non-motor symptom burden. Furthermore, microstructural properties of distinct brain regions were associated with postoperative changes in sleep, attention/memory, urinary symptoms, and apathy. In conclusion, diffusion MRI could support preoperative patient counselling by identifying patients with above- or below-average non-motor responses.
© 2024. The Author(s).
Conflict of interest statement
PAL was supported by the SUCCESS-Program of the Philipps-University of Marburg and the ‘Stiftung zur Förderung junger Neurowissenschaftler’. MBo is a scientific consultant for Brainlab. HSD was funded by the EU Joint Programme – Neurodegenerative Disease Research (JPND), the Prof. Klaus Thiemann Foundation in the German Society of Neurology, the Felgenhauer Foundation, the KoelnFortune program of the Medical Faculty of the University of Cologne and has received honoraria by Everpharma, Kyowa Kirin, Bial, Oruen, and Stadapharm. SS reports no financial disclosures. SK reports no financial disclosures. CN is a scientific consultant for Brainlab. LT received payments as a consultant for Medtronic Inc. and Boston Scientific and received honoraria as a speaker on symposia sponsored by Bial, Zambon Pharma, UCB Schwarz Pharma, Desitin Pharma, Medtronic, Boston Scientific, and Abbott. The institution of LT, not LT personally, received funding by the German Research Foundation, the German Ministry of Education and Research, and Deutsche Parkinson Vereinigung. DJP has received honoraria for speaking at symposia sponsored by Boston Scientific Corp, Medtronic, AbbVie Inc, Zambon and Esteve Pharmaceuticals GmbH. He has received honoraria as a consultant for Boston Scientific Corp and Bayer, and he has received a grant from Boston Scientific Corp for a project entitled “Sensor-based optimisation of Deep Brain Stimulation settings in Parkinson’s disease” (COMPARE-DBS). The institution of DJP, not DJP personally, has received funding from the German Research Foundation, the German Ministry of Education and Research, the International Parkinson Foundation, the Horizon 2020 programme of the EU Commission and the Pohl Foundation in Marburg. Finally, DJP has received travel grants to attend congresses from Esteve Pharmaceuticals GmbH and Boston Scientific Corp. MBe reports no financial disclosures.
Figures


Similar articles
-
No evidence for an association of voxel-based morphometry with short-term non-motor outcomes in deep brain stimulation for Parkinson's disease.NPJ Parkinsons Dis. 2024 Apr 26;10(1):91. doi: 10.1038/s41531-024-00695-1. NPJ Parkinsons Dis. 2024. PMID: 38671017 Free PMC article.
-
Non-motor outcomes depend on location of neurostimulation in Parkinson's disease.Brain. 2019 Nov 1;142(11):3592-3604. doi: 10.1093/brain/awz285. Brain. 2019. PMID: 31553039
-
Mapping Motor Pathways in Parkinson's Disease Patients with Subthalamic Deep Brain Stimulator: A Diffusion MRI Tractography Study.Neurol Ther. 2022 Jun;11(2):659-677. doi: 10.1007/s40120-022-00331-1. Epub 2022 Feb 14. Neurol Ther. 2022. PMID: 35165822 Free PMC article.
-
Congress of Neurological Surgeons Systematic Review and Evidence-Based Guideline on Subthalamic Nucleus and Globus Pallidus Internus Deep Brain Stimulation for the Treatment of Patients With Parkinson's Disease: Executive Summary.Neurosurgery. 2018 Jun 1;82(6):753-756. doi: 10.1093/neuros/nyy037. Neurosurgery. 2018. PMID: 29538685 Free PMC article.
-
Deep brain stimulation for Parkinson's disease: meta-analysis of results of randomized trials at varying lengths of follow-up.J Neurosurg. 2018 Apr;128(4):1199-1213. doi: 10.3171/2016.11.JNS16715. Epub 2017 Jun 30. J Neurosurg. 2018. PMID: 28665252
Cited by
-
No evidence for an association of voxel-based morphometry with short-term non-motor outcomes in deep brain stimulation for Parkinson's disease.NPJ Parkinsons Dis. 2024 Apr 26;10(1):91. doi: 10.1038/s41531-024-00695-1. NPJ Parkinsons Dis. 2024. PMID: 38671017 Free PMC article.
-
Boundary complexity of cortical and subcortical areas predicts deep brain stimulation outcomes in Parkinson's disease.Nat Commun. 2025 Jul 1;16(1):5590. doi: 10.1038/s41467-025-60695-4. Nat Commun. 2025. PMID: 40595525 Free PMC article.
-
Long-Term Effects of Deep Brain Stimulation on Non-Motor Symptoms in Patients with Parkinson's Disease.Ann Indian Acad Neurol. 2025 Jul 1;28(4):519-526. doi: 10.4103/aian.aian_229_25. Epub 2025 Aug 13. Ann Indian Acad Neurol. 2025. PMID: 40820836 Free PMC article.
-
Microstructure is associated with motor outcomes following Deep Brain Stimulation in Parkinson's disease.NPJ Parkinsons Dis. 2025 Apr 21;11(1):81. doi: 10.1038/s41531-025-00930-3. NPJ Parkinsons Dis. 2025. PMID: 40258828 Free PMC article.
References
-
- Gronostay, A. et al. Stratifying quality of life outcome in subthalamic stimulation for Parkinson’s disease. J. Neurol. Neurosurg. Psychiat. 2023. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials